ArticleCancer pathogenesis and therapy2023

Combination of two target agonists of the thrombopoietin and thrombopoietin receptor in the treatment of elderly patients with refractory immune thrombocytopenia.

Jundong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.